Skip to main content
CRL
NYSE Life Sciences

Charles River Lifts Profit Forecast on Biotech Demand Rebound

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$253
Mkt Cap
$11.277B
52W Low
$144.26
52W High
$242.73
52W Position info
75% above low
Off High info
at 52W high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CRL sits 75% above its 52-week low of $144.26.

Summary

Charles River beat Q2 estimates and raised its full-year profit outlook, signaling a genuine recovery in biotech spending. Revenue hit $1 billion vs. the $975.7 million consensus, and adjusted EPS of $3.02 trounced the $2.74 estimate. The company now sees 2026 adjusted EPS of $11.15-$11.45, up from $10.80-$11.30, driven by improving demand in its Discovery and Safety Assessment segment and better Manufacturing performance. This follows a Q1 net loss tied to divestitures, making the organic demand rebound the key takeaway. The stock is already near a 52-week high, so the guidance raise validates the recent run.

Updates

  1. · dpa-AFX — GAAP EPS guidance was cut to $3.05-$3.35 due to divestiture losses, and shares rose 8.8% pre-market to $254.73.

At the time of this announcement, CRL was trading at $253.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $144.26 to $242.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CRL - Latest Insights

CRL
Nov 09, 2026, 6:10 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $337.44
Real-time Price: $341.00 info
Change: +$3.56 (+1%) info
Market Cap: $16.331B info
CRL
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $341.00 info
Change: -$1.99 (-0.58%) info
Market Cap: $16.331B info
CRL
Nov 04, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $362.01
Real-time Price: $341.00 info
Change: -$21.01 (-6%) info
Market Cap: $16.331B info
CRL
Nov 04, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $362.00
Real-time Price: $341.00 info
Change: -$21.00 (-6%) info
Market Cap: $16.331B info
CRL
Sep 24, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $278.01
Real-time Price: $341.00 info
Change: +$62.99 (+23%) info
Market Cap: $16.331B info